Emmanuelle Charpentier active positions
| Companies | Position | Start | End |
|---|---|---|---|
ERS Genomics Ltd.
 ERS Genomics Ltd. BiotechnologyHealth Technology ERS Genomic Ltd. engages in the development of biotechnology. It was formed to provide broad access to the foundational CRISPR-Cas9, a new genome editing technology, which offers speed, efficiency, and cost over earlier genome editing methods. The company was founded by Emmanuelle Charpentier and Shaun Foy in 2014 and is headquartered in Dublin, Ireland. | Founder | 01/01/2014 | - |
| Corporate Officer/Principal | 01/01/2014 | - |
Career history of Emmanuelle Charpentier
Former positions of Emmanuelle Charpentier
| Companies | Position | Start | End |
|---|---|---|---|
| CRISPR THERAPEUTICS AG | Founder | 31/10/2013 | - |
Statistics
International
| Switzerland | 2 |
| Ireland | 2 |
Operational
| Founder | 2 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Private companies | 1 |
|---|---|
ERS Genomics Ltd.
ERS Genomics Ltd. BiotechnologyHealth Technology ERS Genomic Ltd. engages in the development of biotechnology. It was formed to provide broad access to the foundational CRISPR-Cas9, a new genome editing technology, which offers speed, efficiency, and cost over earlier genome editing methods. The company was founded by Emmanuelle Charpentier and Shaun Foy in 2014 and is headquartered in Dublin, Ireland. | Health Technology |
